Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis

Neurobiology of Disease

Volumn 10, Issue 3, 2002, Pages 358-365

  Dupuis, Luc ^a   Gonzalez de Aguilar, Jose Luis ^a   Di Scala, Franck ^a   Rene, Frédérique ^a   De Tapia, Marc ^a   Pradat, Pierre François ^b   Lacomblez, Lucette ^b   Seihlan, Danielle ^b   Prinjha, Rabinder ^c   Walsh, Frank S ^c   Meininger, Vincent ^b   Loeffler, Jean Philippe ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; PROTEIN; PROTEIN NOGO A; PROTEIN NOGO C; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENERVATION; DISEASE MARKER; HUMAN; HUMAN TISSUE; HYBRIDIZATION; MALE; MOLECULAR CLONING; MOUSE; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0036403767     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2002.0522     Document Type: Article

References (23)

1. Bregman, B. S., Kunkel-Bagden, E., Schnell, L., Dai, H. N., Gao, D., & Schwab, M. E. (1995) Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors. Nature 378, 498-501.
2. Brittis, P. A., & Flanagan, J. (2001) Nogo domains and a Nogo receptor: Implications for axon regeneration. Neuron 30, 11-14.
3. Brooks, B. (1994) El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J. Neurol. Sci. 124, 96-107.
4. Brown, R. H., Jr. (1995) Superoxide dismutase in familial amyotrophic lateral sclerosis: Models for gain of function. Curr. Opin. Neurobiol. 5, 841-846.
5. Caroni, P., & Schwab, M. E. (1988) Antibody against myelin-associated inhibitor of neurite growth neutralizes nonpermissive substrate properties of CNS white matter. Neuron 1, 85-96.
6. Chen, M. S., Huber, A. B., Van der Haar, M. E., Frank, M., Schnell, L., Spillmann, A. A., Christ, F., & Schwab, M. E. (2000) Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 403, 434-439.
7. Chomczynski, P., & Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
8. Duclert, A., & Changeux, J. P. (1995) Acetylcholine receptor gene expression at the developing neuromuscular junction. Physiol. Rev. 75, 339-368.
9. Dupuis, L., De Tapia, M., Rene, F., Lutz-Bucher, B., Gordon, J. W., Mercken, L., Pradier, L., & Loeffler, J. P. (2000) Differential screening of mutated SOD1 transgenic mice reveals early up-regulation of a fast axonal transport component in spinal cord motor neurons. Neurobiol. Dis. 7, 274-285.
10. Dupuis, L., Mbebi, C., Gonzalez de Aguilar, J. L., Rene, F., Muller, A., De Tapia, M., & Loeffler, J. P. (2002) Loss of prion protein in a transgenic model of amyotrophic lateral sclerosis. Mol. Cell. Neurosci. 19, 216-224.
11. Eisen, A. A. (1995) Amyotrophic lateral sclerosis. A multifactorial disease. Adv. Neurol. 68, 121-134.
12. Fridovich, I. (1986) Superoxide dismutases. Adv. Enzymol. 58, 61-97.
13. GrandPre, T., Nakamura, F., Vartanian, T., & Strittmatter, S. M. (2000) Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature 403, 439-444.
14. Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H. X., et al. (1994) Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264, 1772-1775.
15. Hurko, O., & Walsh, F. S. (2000) Novel drug development for amyotrophic lateral sclerosis. J. Neurol. Sci. 180, 21-28.
16. Ince, P., Lowe, J., & Shaw, P. (1998) Amyotrophic lateral sclerosis: Current issues in classification, pathogenesis and molecular pathology. Neuropathol. Appl. Neurobiol. 24, 104-117.
17. Josephson, A., Widenfalk, J., Widmer, H. W., Olson, L., & Spenger, C. (2001) NOGO mRNA expression in adult and fetal human and rat nervous tissue and in weight drop injury. Exp Neurol. 169, 319-328.
18. Meininger, V., Lacomblez, L., & Salachas, F. (2000) What has changed with riluzole? J. Neurol. 247 (Suppl. 6), VI/19-VI/22.
19. Prinjha, R., Moore, S. E., Vinson, M., Blake, S., Morrow, R., Christie, G., Michalovich, D., Simmons, D. L., & Walsh, F. S. (2000) Inhibitor of neurite outgrowth in humans. Nature 403, 383-384.
20. Ripps, M. E., Huntley, G. W., Hof, P. R., Morrison, J. H., & Gordon, J. W. (1995) Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA 92, 689-693.
21. Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H. X., et al. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59-62.
22. Sambrook, J., Fritsch, E. F., & Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
23. Wong, P. C., Pardo, C. A., Borchelt, D. R., Lee, M. K., Copeland, N. G., Jenkins, N. A., Sisodia, S. S., Cleveland, D. W., & Price, D. L. (1995) An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14, 1105-1116.